Stay updated on Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial
Sign up to get notified when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.

Latest updates to the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA new 'Sample Collection' entry was added on 2026-05-13, and the study documentation was updated to Revision: v3.5.4 on 2026-05-12, replacing Revision: v3.5.3.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a maintenance release of the site rather than any change to the clinical trial record content.SummaryDifference0.0%

- Check36 days agoChange DetectedAdded 2026-04-13 Revision: v3.5.2 and removed 2026-04-08 Revision: v3.5.0.SummaryDifference0.1%

- Check44 days agoChange DetectedTwo new study record update dates (April 8 and April 9, 2026) were added, and two earlier dates (April 2 and April 3, 2026) were removed.SummaryDifference0.1%

- Check51 days agoChange DetectedTwo new update dates (2026-04-02 and 2026-04-03) were added to the study record history, reflecting recent page updates.SummaryDifference0.1%

- Check58 days agoChange DetectedThe Study Record Dates were updated to include new entries dated 2026-03-27 and 2026-03-26, and to remove entries dated 2026-03-20 and 2026-03-19.SummaryDifference0.1%

Stay in the know with updates to Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.